Bio-Rad Laboratories | BIO - Operating Expenses

Stock Price
287.84
Daily Change
6.42 2.28%
Monthly
5.20%
Yearly
18.77%
Q2 Forecast
281.68

Bio-Rad Laboratories reported $6.74B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Agilent USD 1.44B 27M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Bruker USD 900.9M 124.3M Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Danaher USD 52.95B 47.61B Mar/2026
General Electric Aerospace USD 18.06B 7.11B Mar/2026
Illumina USD 903M 69M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Merck USD 10.16B 558M Dec/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quest Diagnostics USD 2.5B 76M Mar/2026
Repligen USD 177.94M 1.82M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Siemens EUR 16.57B 2.29B Dec/2025
Standard Biotools USD 45.72M 2.7M Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Tosoh JPY 231.79B 6.44B Dec/2025
Waters USD 661.85M 1.67B Dec/2025